Resources from the same session
Invited Discussant LBA45 and 746MO
Presenter: Kosei Hasegawa
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
745MO - Raludotatug deruxtecan (R-DXd; DS-6000) monotherapy in patients with previously treated ovarian cancer (OVC): Subgroup analysis of a first-in-human phase I study
Presenter: Kathleen Moore
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
747MO - First results from the ENGOT-GYN2/GOG-3051/BOUQUET phase II biomarker-directed platform study: Cobimetinib (cobi) or atezolizumab (atezo) + bevacizumab (bev) for persistent/recurrent rare epithelial ovarian cancer (eOC)
Presenter: Isabelle Ray-Coquard
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant 745MO and 747MO
Presenter: Mansoor Raza Mirza
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast